Celiprolol pneumonitis. 1993

J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
Service de Pneumologie et de Réanimation Respiratoire, Centre Hospitalier Universitaire, Dijon, France.

We report on a patient who developed hypersensitivity pneumonitis during treatment with the beta-blocker, celiprolol. The clinical picture was a severe alveolitis, with compromised gas exchange. Inadvertent subsequent rechallenge with celiprolol led to recurrence of the pneumonitis, 10 weeks after drug readministration. Again, the pneumonitis was fully reversible. Lymphocytes were elevated in bronchoalveolar lavage, and progressively normalized upon discontinuation of the drug. This case is reminiscent of pneumonitis to other beta-blockers, which are reviewed here.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000542 Alveolitis, Extrinsic Allergic A common interstitial lung disease caused by hypersensitivity reactions of PULMONARY ALVEOLI after inhalation of and sensitization to environmental antigens of microbial, animal, or chemical sources. The disease is characterized by lymphocytic alveolitis and granulomatous pneumonitis. Allergic Alveolitis, Extrinsic,Hypersensitivity Pneumonitis,Pneumonitis, Hypersensitivity,Allergic Alveolitides, Extrinsic,Alveolitides, Extrinsic Allergic,Extrinsic Allergic Alveolitides,Extrinsic Allergic Alveolitis,Hypersensitivity Pneumonitides,Pneumonitides, Hypersensitivity
D017272 Celiprolol A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION. Celiprolol Hydrochloride,Celiprolol Monohydrochloride,Celiprolol, (+,-)-Isomer,Celiprolol, (R)-Isomer,Celiprolol, (S)-Isomer,Celiprolol, Monohydrochloride, (R)-Isomer,Celiprolol, Monohydrochloride, (S)-Isomer,N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea,REV-5320A,ST-1396,Selectol,Hydrochloride, Celiprolol,Monohydrochloride, Celiprolol,REV 5320A,REV5320A,ST 1396,ST1396

Related Publications

J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
January 1988, Revista de medicina de la Universidad de Navarra,
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
April 1992, Lancet (London, England),
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
January 1992, Lancet (London, England),
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
November 1988, American heart journal,
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
August 1996, Journal of chromatography. B, Biomedical applications,
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
November 1988, American heart journal,
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
January 1991, Cardiovascular drugs and therapy,
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
December 1991, Lancet (London, England),
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
November 1988, American heart journal,
J N Lombard, and B Bonnotte, and M Maynadie, and P Foucher, and O Reybet Degat, and L Jeannin, and P Camus
November 1988, American heart journal,
Copied contents to your clipboard!